Preoperative anemia or low hemoglobin predicts poor prognosis in gastric cancer patients: A meta-analysis

Disease Markers

Volumn 2019, Issue , 2019, Pages

  Huang, Xuan Zhang ^a   Yang, Yu Chong ^b   Chen, You ^c   Wu, Cong Cong ^a   Lin, Rui Fang ^a   Wang, Zhen Ning ^d   Zhang, Xi ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c The Wenzhou Dental Hospital   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ANEMIA; CANCER PROGNOSIS; CANCER STAGING; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; META ANALYSIS; OVERALL SURVIVAL; PREOPERATIVE PERIOD; REVIEW; STOMACH CANCER; BLOOD; METABOLISM; STOMACH TUMOR;

ANEMIA; DISEASE-FREE SURVIVAL; HEMOGLOBINS; HUMANS; PREOPERATIVE PERIOD; STOMACH NEOPLASMS;

EID: 85061140933     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2019/7606128     Document Type: Review

References (51)

1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87-108, 2015.
2. S. B. Edge and C. C. Compton, “The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1471-1474, 2010.
3. S. C. Wang, J. F. Chou, V. E. Strong, M. F. Brennan, M. Capanu, and D. G. Coit, “Pretreatment neutrophil to lymphocyte ratio independently predicts disease-specific survival in resectable gastroesophageal junction and gastric adenocarcinoma,” Annals of Surgery, vol. 263, no. 2, pp. 292-297, 2016.
4. X. Sun, X. Liu, J. Liu et al., “Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer,” Chinese Journal of Cancer, vol. 35, no. 1, p. 57, 2016.
5. E. Y. Kim, J. W. Lee, H. M. Yoo, C. H. Park, and K. Y. Song, “The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: which is better as a prognostic factor in gastric cancer?,” Annals of Surgical Oncology, vol. 22, no. 13, pp. 4363-4370, 2015.
6. S. Song, C. Li, S. Li, H. Gao, X. Lan, and Y. Xue, “Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer,” OncoTargets and Therapy, vol. Volume 10, pp. 3145-3154, 2017.
7. A. Stang, “Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603-605, 2010.
8. N. Panic, E. Leoncini, G. de Belvis, W. Ricciardi, and S. Boccia, “Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses,” PLoS One, vol. 8, no. 12, article e83138, 2013.
9. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, “Practical methods for incorporating summary time-to-event data into meta-analysis,” Trials, vol. 8, no. 1, p. 16, 2007.
10. J. P. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557-560, 2003.
11. C. H. Schmid, P. C. Stark, J. A. Berlin, P. Landais, and J. Lau, “Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors,” Journal of Clinical Epidemiology, vol. 57, no. 7, pp. 683-697, 2004.
12. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629-634, 1997.
13. C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088-1101, 1994.
14. S. Duval and R. Tweedie, “Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis,” Biometrics, vol. 56, no. 2, pp. 455-463, 2000.
15. X. Liu, H. Qiu, Y. Huang et al., “Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single-institution retrospective analysis of 2163 Chinese patients,” Cancer Medicine, vol. 7, no. 2, pp. 360-369, 2018.
16. S. L. Wang, L. L. Ma, X. Y. Chen et al., “Impact of visceral fat on surgical complications and long-term survival of patients with gastric cancer after radical gastrectomy,” European Journal of Clinical Nutrition, vol. 72, no. 3, pp. 436-445, 2018.
17. L. Chen, Y. Yan, L. Zhu et al., “Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoad-juvant chemotherapy,” Cancer Management and Research, vol. 9, pp. 849-867, 2017.
18. F. Xue, F. Lin, M. Yin et al., “Preoperative albumin/globulin ratio is a potential prognosis predicting biomarker in patients with resectable gastric cancer,” Turkish Journal of Gastroenterology, vol. 28, no. 6, pp. 439-445, 2017.
19. G. Wu, D. Y. Zhang, Y. H. Duan, Y. Q. Zhang, X. N. Cui, and Z. Luo, “Correlations of hemoglobin level and perioperative blood transfusion with the prognosis of gastric cancer: a retrospective study,” Medical Science Monitor, vol. 23, pp. 2470-2478, 2017.
20. J. W. Lee, M. S. Lee, I. K. Chung, M. W. Son, Y. S. Cho, and S. M. Lee, “Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection,” World Journal of Gastroenterology, vol. 23, no. 13, pp. 2385-2395, 2017.
21. D. Hu, H. Zhang, X. Lin et al., “Elevated preoperative neutrophil-to-lymphocyte ratio can predict poor survival in early stage gastric cancer patients receiving radical gastrectomy: the Fujian prospective investigation of cancer (FIESTA) study,” Journal of Digestive Diseases, vol. 8, no. 7, pp. 1214-1222, 2017.
22. Y. Shu, J. Qian, Y. Qian et al., “A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy,” Drug Design, Development and Therapy, vol. 10, pp. 241-258, 2016.
23. J. Cui, J. Deng, X. Ding et al., “Blood transfusion does not affect survival of gastric cancer patients,” Journal of Surgical Research, vol. 200, no. 1, pp. 98-104, 2016.
24. W. K. Eo, D. W. Jeong, H. J. Chang et al., “Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer,” World Journal of Gastroenterology, vol. 21, no. 9, pp. 2668-2676, 2015.
25. H. Y. Zhou, W. Yi, J. Wang, J. Zhang, W. J. Wang, and Z. Q. Hu, “Association of perioperative allogeneic blood transfusions and prognosis of patients with gastric cancer after curative gastrectomy,” American Journal of Surgery, vol. 208, no. 1, pp. 80-87, 2014.
26. S. Rausei, L. Ruspi, F. Galli et al., “Peri-operative blood transfusion in gastric cancer surgery: prognostic or confounding factor?,” International Journal of Surgery, vol. 11, Supplement 1, pp. S100-S103, 2013.
27. Y. Mohri, K. Tanaka, M. Ohi, T. Yokoe, C. Miki, and M. Kusunoki, “Prognostic significance of host- and tumor-related factors in patients with gastric cancer,” World Journal of Surgery, vol. 34, no. 2, pp. 285-290, 2010.
28. E. A. Gorbunov, J. Wechsler, J. Stašek, A. S. Tomin, and L. D. Solodun, “Significant prognostic factors in 283 patients after surgery for adenocarcinoma of the stomach,” Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae, vol. 78, no. 1, pp. 3-16, 2005.
29. J. G. Shen, J. H. Cheong, W. J. Hyung, J. Kim, S. H. Choi, and S. H. Noh, “Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer,” Journal of Surgical Oncology, vol. 91, no. 2, pp. 126-130, 2005.
30. C. W. Wu, M. C. Hsieh, S. S. Lo et al., “Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach,” Digestive Diseases and Sciences, vol. 42, no. 6, pp. 1265-1269, 1997.
31. G. R. Jatzko, P. H. Lisborg, H. Denk, M. Klimpfinger, and H. M. Stettner, “A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan,” Cancer, vol. 76, no. 8, pp. 1302-1312, 1995.
32. J. Griniatsos, I. Papaconstantinou, E. Felekouras, P. O. Michail, C. Bakoyiannis, and J. Bramis, “The significance of perioperative anemia in patients with resectable gastrointestinal tract tumors,” Journal of BUON, vol. 9, no. 3, pp. 247-253, 2004.
33. K. Knight, S. Wade, and L. Balducci, “Prevalence and outcomes of anemia in cancer: a systematic review of the literature,” The American Journal of Medicine, vol. 116, no. 7, Supplement 1, pp. 11-26, 2004.
34. S. Mercadante, V. Gebbia, A. Marrazzo, and S. Filosto, “Anaemia in cancer: pathophysiology and treatment,” Cancer Treatment Reviews, vol. 26, no. 4, pp. 303-311, 2000.
35. G. Weiss and L. T. Goodnough, “Anemia of chronic disease,” The New England Journal of Medicine, vol. 352, no. 10, pp. 1011-1023, 2005.
36. G. Birgegård, M. S. Aapro, C. Bokemeyer et al., “Cancer-related anemia: pathogenesis, prevalence and treatment,” Oncology, vol. 68, no. 1, pp. 3-11, 2005.
37. M. J. Wilson, M. van Haaren, J. J. Harlaar et al., “Long-term prognostic value of preoperative anemia in patients with colo-rectal cancer: a systematic review and meta-analysis,” Surgical Oncology, vol. 26, no. 1, pp. 96-104, 2017.
38. L. Xia and T. J. Guzzo, “Preoperative anemia and low hemoglobin level are associated with worse clinical outcomes in patients with bladder cancer undergoing radical cystectomy: a meta-analysis,” Clinical Genitourinary Cancer, vol. 15, no. 2, pp. 263-272.e4, 2017.
39. F. Zhang, F. Cheng, L. Cao, S. Wang, W. Zhou, and W. Ma, “A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinoma,” World Journal of Surgical Oncology, vol. 12, no. 1, p. 244, 2014.
40. P. Vaupel, O. Thews, and M. Hoeckel, “Treatment resistance of solid tumors: role of hypoxia and anemia,” Medical Oncology, vol. 18, no. 4, pp. 243-260, 2001.
41. P. Vaupel, “The role of hypoxia-induced factors in tumor progression,” The Oncologist, vol. 9, Supplement 5, pp. 10-17, 2004.
42. G. U. Dachs and G. M. Tozer, “Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation,” European Journal of Cancer, vol. 36, no. 13, pp. 1649-1660, 2000.
43. G. L. Semenza, “Hypoxia, clonal selection, and the role of HIF-1 in tumor progression,” Critical Reviews in Biochemistry and Molecular Biology, vol. 35, no. 2, pp. 71-103, 2000.
44. A. Coquelle, F. Toledo, S. Stern, A. Bieth, and M. Debatisse, “A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs,” Molecular Cell, vol. 2, no. 2, pp. 259-265, 1998.
45. H. Ludwig, S. van Belle, P. Barrett-Lee et al., “The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients,” European Journal of Cancer, vol. 40, no. 15, pp. 2293-2306, 2004.
46. D. H. Jung, H. J. Lee, D. S. Han et al., “Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery,” Gastric Cancer, vol. 16, no. 3, pp. 377-382, 2013.
47. J. B. Y. So, A. Yam, W. K. Cheah, C. K. Kum, and P. M. Y. Goh, “Risk factors related to operative mortality and morbidity in patients undergoing emergency gastrectomy,” British Journal of Surgery, vol. 87, no. 12, pp. 1702-1707, 2000.
48. L. Xue, X. L. Chen, Z. Wei-Han et al., “Impact of perioperative blood transfusion on postoperative complications and prognosis of gastric adenocarcinoma patients with different preoperative hemoglobin value,” Gastroenterology Research and Practice, vol. 2016, Article ID 6470857, 10 pages, 2016.
49. T. Ojima, M. Iwahashi, M. Nakamori et al., “Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy,” Journal of Gastrointestinal Surgery, vol. 13, no. 10, pp. 1821-1830, 2009.
50. C. Sun, Y. Wang, H. S. Yao, and Z. Q. Hu, “Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis,” International Journal of Surgery, vol. 13, pp. 102-110, 2015.
51. C. C. Chang, J. T. Sun, J. Y. Chen et al., “Impact of perioperative anemia and blood transfusions in patients with gastric cancer receiving gastrectomy,” Asian Pacific Journal of Cancer Prevention, vol. 17, no. 3, pp. 1427-1431, 2016.